These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 22304668)
21. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea. Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481 [TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193 [TBL] [Abstract][Full Text] [Related]
24. Herpes zoster vaccine: clinical trial evidence and implications for medical practice. Burke MS J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883 [TBL] [Abstract][Full Text] [Related]
25. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly. Opstelten W; van Essen GA; Hak E Vaccine; 2009 Jan; 27(2):192-6. PubMed ID: 18996427 [TBL] [Abstract][Full Text] [Related]
29. Concomitant administration of pneumococcal-23 and zoster vaccines provides adequate herpes zoster coverage. Wyman MJ; Stabi KL Ann Pharmacother; 2013; 47(7-8):1064-8. PubMed ID: 23715069 [TBL] [Abstract][Full Text] [Related]
30. Zoster vaccine: current status and future prospects. Oxman MN Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454 [TBL] [Abstract][Full Text] [Related]
31. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines]. Afonina NM; Mikheeva IV Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613 [TBL] [Abstract][Full Text] [Related]
32. Ten years of experience with herpes zoster vaccine in primary care- how attitudes and practices have changed and what it may mean for a new zoster vaccine. Guo A; Lindley MC; Hurley LP; Allen JA; Allison MA; O'Leary ST; Crane LA; Brtnikova M; Beaty BL; Kempe A; Dooling KL Vaccine; 2019 Sep; 37(37):5509-5512. PubMed ID: 31400911 [TBL] [Abstract][Full Text] [Related]
34. Herpes zoster vaccine. Poorly effective in those who need it most. Prescrire Int; 2012 Dec; 21(133):291. PubMed ID: 23373094 [TBL] [Abstract][Full Text] [Related]
35. Trends and disparity in zoster vaccine uptake in a managed care population. Hechter RC; Tartof SY; Jacobsen SJ; Smith N; Tseng HF Vaccine; 2013 Sep; 31(41):4564-8. PubMed ID: 23928461 [TBL] [Abstract][Full Text] [Related]
36. Zoster vaccine in older adults. Fried R J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342 [No Abstract] [Full Text] [Related]
37. Herpes zoster vaccination: benefits and barriers. Komara FA J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S22-4. PubMed ID: 19553633 [TBL] [Abstract][Full Text] [Related]
38. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039 [TBL] [Abstract][Full Text] [Related]
39. Prevention of shingles by varicella zoster virus vaccination. Holodniy M Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624 [TBL] [Abstract][Full Text] [Related]